Seizure frequency and obstetric complications at advanced maternal age: a preliminary observational study in women with epilepsy

[1]  J. Zamora,et al.  Global variation in pregnancy complications in women with epilepsy: A meta-analysis. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[2]  M. Sauer.  Reproduction at an advanced maternal age and maternal health. , 2015, Fertility and sterility.

[3]  Dong Zhou,et al.  Periconceptional folic acid supplementation among pregnant women with epilepsy in a developing country: A retroprospective survey in China , 2015, Epilepsy & Behavior.

[4]  M. C. Canavarro,et al.  Characteristics of primiparous women of advanced age and their partners: a homogenous or heterogenous group? , 2014, Birth.

[5]  T. Tomson,et al.  Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry , 2013, Epilepsia.

[6]  N. Gilhus,et al.  Obstetric outcome in women with epilepsy: a hospital‐based, retrospective study , 2011, BJOG : an international journal of obstetrics and gynaecology.

[7]  S. B. Lucas,et al.  Pregnancy with epilepsy: Obstetric and neonatal outcome of a controlled study , 2010, Seizure.

[8]  C. Bearer.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2007 .

[9]  S. Kochen,et al.  Seizure control and treatment in pregnancy , 2006, Neurology.

[10]  B. Irwin,et al.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  J. Detoledo.  Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. , 2006, Neurology.

[12]  L. Holmes,et al.  Increased rate of major malformations in offspring exposed to valproate during pregnancy , 2005, Neurology.

[13]  S. Endo,et al.  Statistics on Deliveries of Mothers with Epilepsy at Yokohama City University Hospital , 2004, Epilepsia.

[14]  T. O'Brien,et al.  Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy , 2004, Journal of Clinical Neuroscience.

[15]  E. Andermann,et al.  Epilepsy and pregnancy: an obstetric perspective. , 2004, American journal of obstetrics and gynecology.

[16]  M. Yerby.  Management issues for women with epilepsy , 2003, Neurology.

[17]  T. O'Brien,et al.  The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months , 2003, Journal of Clinical Neuroscience.

[18]  D. Walshaw,et al.  Population based, prospective study of the care of women with epilepsy in pregnancy , 2000, BMJ : British Medical Journal.

[19]  G. Avanzini,et al.  Malformations in Offspring of Women with Epilepsy: A Prospective Study , 1999, Epilepsia.

[20]  M. Mrcp,et al.  Outcome of pregnancies in epileptic women: a study in Saudi Arabia , 1999, Seizure.

[21]  M. Morrell,et al.  Management issues for women with epilepsy , 1998, Neurology.

[22]  W. Hauser,et al.  Pregnancies of Women with Epilepsy: A Population‐Based Study in Iceland , 1998, Epilepsia.

[23]  M. Morrell,et al.  Management with issues for women epilepsy A review of the literature , 1998 .